Key messages

  • A pharmaceutical governance system grounded in international human rights, particularly the right to health and access to drugs, could help achieve equitable access to costly drugs
  • A human rights due diligence approach could be used to promote government compliance with human rights while working towards national and international legislation
  • This approach could also be used to ensure corporate action to promote availability, accessibility, acceptability, and quality of drugs for rare diseases